Evidence map›Paper›PMID 38464842›Full record

ArticleFrontiers in cardiovascular medicine2024

A wolf in sheep's clothing-aortic stenosis and cardiac amyloidosis: "RAISE"ing awareness in clinical practice.

H Sabbour, K Al-Humood, Z Al Taha, I Romany, H Haddadin, D Mohty

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cardiac transthyretin amyloidosis in aortic valve replacement: RAISE score performance in the postoperative setting.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

H SabbourHeart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
K Al-HumoodAdvanced Heart Failure and Transplantation Unit, Chest Disease Hospital, Kuwait City, Kuwait.
Z Al TahaSheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
I RomanyPfizer Gulf FZ LLC, Dubai, United Arab Emirates.
H HaddadinPfizer Gulf FZ LLC, Dubai, United Arab Emirates.
D MohtyHeart Center, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aesop's fable of the wolf in sheep's clothing encourages us to look beneath the exterior appearance of a situation and evaluate the truth that lies beneath. This concept should be applied when managing older patients with severe aortic stenosis. This population of patients is increasingly being identified as having concomitant cardiac amyloidosis, which is an underrecognized cause of common cardiac conditions. The presence of cardiac amyloidosis negatively affects the outcome of patients with aortic stenosis, these patients undergo transcatheter aortic valve replacement (TAVR) with increasing frequency and have a significantly higher overall mortality rate than patients with aortic stenosis alone. Although left ventricular wall hypertrophy is expected in patients with aortic stenosis, it should not be assumed that this is caused only by aortic stenosis. A suspicion of cardiac amyloidosis should be raised in patients in whom the degree of hypertrophy is disproportionate to the degree of aortic stenosis severity. The remodeling, age, injury, systemic, and electrical (RAISE) score was developed to predict the presence of cardiac amyloidosis in patients with severe aortic stenosis. This article highlights the value of increased clinical suspicion, demonstrates the use of the multiparameter RAISE score in daily clinical practice, and illustrates the scoring system with case studies. In elderly patients being considered for TAVR, systematic testing for cardiac amyloidosis should be considered as part of the preoperative workup.

Indexed as

aortic stenosiscardiac amyloidosisdiagnosisheart failurelow-flow/low-gradientRAISE scoretransthyretin

Identifiers

PMID38464842
PMCPMC10921426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.